Research Article

Integrated Metabolomic and Lipidomic Analysis Reveals the Neuroprotective Mechanisms of Bushen Tiansui Formula in an Aβ1-42-Induced Rat Model of Alzheimer’s Disease

Table 5

Differentially expressed lipids detected by LC-MS/MS.

Lipid ionClassIon formulaRt (min)AD vs. shamBSTSF vs. AD
VIPFCVIPFC

ESI+
 Cer(d18:1/24:1)CerC42 H82 O3 N1648.628918.242520.0161.4201.373
 PE(20:3e)PEC25 H46 O7 N1 P1 Na1526.29043.1409120.0041.1021.646
 Cer(d18:1/18:0)CerC36 H72 O3 N1566.550715.298910.0076.8051.5290.0021.7240.646
 Cer(d20:1/18:0)CerC38 H76 O3 N1594.58216.735160.0031.8981.507
 LPC(16:0)LPCC24 H51 O7 N1 P1496.33984.2668470.0412.0161.533
 Cer(d18:2/20:2)CerC38 H70 O3 N1588.53515.197710.0333.1741.3040.0032.5370.747
 LPC(18:0)LPCC26 H55 O7 N1 P1524.37115.9938060.0461.2111.417
 PC(32:1e)PCC40 H81 O7 N1 P1718.574514.227060.0071.0140.718
 PC(38:4)PCC46 H85 O8 N1 P1810.600713.761290.0113.0160.872
 PE(16:0p/20:4)PEC41 H75 O7 N1 P1724.527613.456750.0182.3910.778
 Cer(d18:2/18:0)CerC36 H70 O3 N1564.53514.09850.0211.1470.784
 PE(37:1p)PEC42 H82 O7 N1 P1 Na1766.572113.063180.0301.8380.735
 PS(18:1/22:6)PSC46 H77 O10 N1 P1834.52811.29690.0331.7180.663
 PC(34:1e)PCC42 H85 O7 N1 P1746.605815.561480.0422.5411.515
ESI-
 PS(20:3/22:6)PSC48 H75 O10 N1 P1856.513411.755410.0301.4060.8150.0211.5371.279
 SM(d16:1/18:0)SMC40 H80 O8 N2 P1747.565811.403320.0201.2800.817
 Cer(d18:1/16:0)CerC35 H68 O5 N1582.510312.798070.0091.9421.367
 Cer(d15:0/20:1)CerC36 H70 O5 N1596.525913.386670.0041.0521.439
 Cer(d36:0)CerC37 H74 O5 N1612.557214.350060.0022.3781.5980.0021.1600.704
 Cer(d16:0/21:1)CerC38 H74 O5 N1624.557214.494070.0141.2541.464
 Cer(d20:1/18:0)CerC39 H76 O5 N1638.572915.258460.0024.9561.3820.0082.9030.811
 Cer(d18:1/22:0)CerC41 H80 O5 N1666.604216.58130.0001.9211.404
 Cer(d18:1/22:1)CerC41 H78 O5 N1664.588515.151090.0181.1711.486
 Cer(d18:1/23:0)CerC42 H82 O5 N1680.619817.287170.0011.3681.431
 Cer(d18:1/24:0)CerC43 H84 O5 N1694.635517.992140.0021.8931.423
 Cer(d18:1/24:1)CerC43 H82 O5 N1692.619816.513470.0143.8811.372
 LPC(16:0)LPCC25 H51 O9 N1 P1540.33073.2368440.0001.1571.460
 LPC(18:0)LPCC27 H55 O9 N1 P1568.3624.9299420.0161.6121.386
 LPC(18:1)LPCC27 H53 O9 N1 P1566.34633.433830.0021.3471.474
 LPC(20:4)LPCC29 H51 O9 N1 P1588.33072.7029410.0231.1671.610
 LPE(20:4)LPEC25 H43 O7 N1 P1500.27832.8307860.0021.6571.552
 LPE(22:6)LPEC27 H43 O7 N1 P1524.27832.6968260.0022.5361.640
 PC(18:0/20:4)PCC47 H85 O10 N1 P1854.591712.647140.0041.5051.1030.0071.6050.907
 PC(16:0/22:5)PCC47 H83 O10 N1 P1852.57612.0420.0461.8051.422
 PE(16:0p/22:6)PEC43 H73 O7 N1 P1746.51311.990960.0163.2481.1120.0093.0560.902
 PE(18:1p/22:6)PEC45 H75 O7 N1 P1772.528712.09790.0091.2021.104
 PG(42:6)PGC48 H82 O10 N0 P1849.565111.759070.0221.4451.248
 PC(16:0/20:4)PCC45 H81 O10 N1 P1826.560411.534140.0051.8250.887
 PE(18:0p/20:4)PEC43 H77 O7 N1 P1750.544313.117350.0092.2260.894
 PE(18:0/22:4)PEC45 H81 O8 N1 P1794.570513.649110.0171.9710.905
 PS(18:0/22:6)PSC46 H77 O10 N1 P1834.529113.471650.0271.3762.309
 PE(34:1e)PEC39 H77 O7 N1 P1702.544313.4970.0301.7891.250
 PE(18:0/20:4)PEC43 H77 O8 N1 P1766.539212.853520.0382.7800.924
 PS(18:0/18:1)PSC42 H79 O10 N1 P1788.544712.644610.0442.4841.284

Notes: BSTSF: Bushen Tiansui Formula; AD: Alzheimer’s disease; RT (min): retention time; VIP: variable importance; FC: fold change. Fold change was calculated as average relative quantitation obtained from group 1/group 2, and a value less than 1 indicates a decrease in the metabolites of group 1.